Table 4 Tumour response
Child–Pugh B subgroup | Overall populationa | |||
|---|---|---|---|---|
Cabozantinib (N = 51) | Placebo (N = 22) | Cabozantinib (N = 467) | Placebo (N = 237) | |
Best overall response, n (%) | ||||
Complete response | 0 | 0 | 0 | 0 |
Partial response | 0 | 0 | 18 (4) | 1 (< 1) |
Stable disease | 29 (57) | 5 (23) | 282 (60) | 78 (33) |
Progressive disease | 21 (41) | 15 (68) | 98 (21) | 131 (55) |
Not evaluable or missing | 1 (2) | 2 (9) | 72 (15) | 27 (11) |